Lineage, Inc. (LINE) Lawsuit – Investors Urged to Contact Levi & Korsinsky Before September 30, 2025

NEW YORK, NY / ACCESS Newswire / September 11, 2025 / If you suffered a loss on your Lineage, Inc. (NASDAQ:LINE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lineage-inc-lawsuit-submission-form?prid=166554&wire=1&utm_campaign=4 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call […]

Maze Therapeutics Announces Positive First-in-Human Results from Phase 1 Trial of MZE782, Establishing Proof of Mechanism for a Potent, Oral SLC6A19 Inhibitor with Potential to Treat Phenylketonuria (PKU) and Chronic Kidney Disease (CKD)

Maze Therapeutics Announces Positive First-in-Human Results from Phase 1 Trial of MZE782, Establishing Proof of Mechanism for a Potent, Oral SLC6A19 Inhibitor with Potential to Treat Phenylketonuria (PKU) and Chronic Kidney Disease (CKD) GlobeNewswire September 11, 2025 Phase 1 data in healthy volunteers exceed expectations and support best-in-class potential, enabling Phase 2 advancement for both

Sky Quarry Appoints Co-Founder Marcus Laun as Interim Chief Executive Officer

Sky Quarry Appoints Co-Founder Marcus Laun as Interim Chief Executive Officer Leadership transition comes as the Company explores digital treasury strategies to complement its integrated energy model GlobeNewswire September 11, 2025 WOODS CROSS, Utah, Sept. 11, 2025 (GLOBE NEWSWIRE) — Sky Quarry Inc. (NASDAQ: SKYQ) (“Sky Quarry” or “the Company”), an integrated energy solutions company,

Apogee Therapeutics Announces Late-Breaker Presentation of 16-Week Data from Phase 2 APEX Trial of APG777 for Moderate-to-Severe Atopic Dermatitis at the Upcoming European Academy of Dermatology and Venereology (EADV) 2025 Congress

Apogee Therapeutics Announces Late-Breaker Presentation of 16-Week Data from Phase 2 APEX Trial of APG777 for Moderate-to-Severe Atopic Dermatitis at the Upcoming European Academy of Dermatology and Venereology (EADV) 2025 Congress GlobeNewswire September 11, 2025 SAN FRANCISCO and BOSTON, Sept. 11, 2025 (GLOBE NEWSWIRE) — Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing

HPQ Awarded Up to $3M in Federal Funding to Fast-Track Commercialization of Silicon-Based Battery Materials

HPQ Awarded Up to $3M in Federal Funding to Fast-Track Commercialization of Silicon-Based Battery Materials GlobeNewswire September 11, 2025 MONTREAL, Sept. 11, 2025 (GLOBE NEWSWIRE) — HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a Quebec-based technology company driving innovation in advanced materials and critical process development, is pleased to

Concentrix Schedules Release of Third Quarter 2025 Financial Results and Investor Conference Call Webcast

Concentrix Schedules Release of Third Quarter 2025 Financial Results and Investor Conference Call Webcast GlobeNewswire September 11, 2025 NEWARK, Calif., Sept. 11, 2025 (GLOBE NEWSWIRE) — Concentrix Corporation (NASDAQ: CNXC), a global technology and services leader, plans to announce its fiscal third quarter 2025 financial results after market close on Thursday, September 25, 2025. The

Class Action Alert: Levi & Korsinsky Reminds Biohaven Ltd. (BHVN) Investors of September 12, 2025 Deadline

NEW YORK, NY / ACCESS Newswire / September 11, 2025 / If you suffered a loss on your Biohaven Ltd. (NYSE:BHVN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/biohaven-ltd-lawsuit-submission-form?prid=166556&wire=1&utm_campaign=17 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Investors Urged to Contact Levi & Korsinsky for Information Before October 20, 2025 – PubMatic, Inc. (PUBM)

NEW YORK, NY / ACCESS Newswire / September 11, 2025 / If you suffered a loss on your PubMatic, Inc. (NASDAQ:PUBM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pubmatic-inc-lawsuit-submission-form?prid=166555&wire=1&utm_campaign=5 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

WONZ Technology Showcases Innovative Product WONZ ta-VNS Device at IFA

Berlin, Germany, Sept. 11, 2025 (GLOBE NEWSWIRE) — At this year's IFA International Consumer Electronics Show, WONZ Technology showcased its latest innovative product – the ta-VNS Device, offering global users a new solution for sleep and health support. ​ As one of the standout health technology products at the exhibition this year, the WONZ ta-VNS

Scroll to Top